The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The global Colorectal Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer.
Report Scope
The Colorectal Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Roche
- Debiopharm
- Merck Kgaa
- Vaccinogen
- Aeterna Zentaris
- Keryx
- Spectrum Pharmaceuticals
- Mologen
- Amgen
- Bayer Healthcare
Segment by Type
- Chemotherapy
- Targeted therapy
- Immunotherapy
Segment by Application
- Early Colorectal Cancer
- Midterm Colorectal Cancer
- Late Colorectal Cancer
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Targeted therapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Colorectal Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Early Colorectal Cancer
1.3.3 Midterm Colorectal Cancer
1.3.4 Late Colorectal Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Market Perspective (2019-2030)
2.2 Colorectal Cancer Growth Trends by Region
2.2.1 Global Colorectal Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Market Dynamics
2.3.1 Colorectal Cancer Industry Trends
2.3.2 Colorectal Cancer Market Drivers
2.3.3 Colorectal Cancer Market Challenges
2.3.4 Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Players by Revenue
3.1.1 Global Top Colorectal Cancer Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Revenue
3.4 Global Colorectal Cancer Market Concentration Ratio
3.4.1 Global Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Revenue in 2023
3.5 Colorectal Cancer Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Breakdown Data by Type
4.1 Global Colorectal Cancer Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Breakdown Data by Application
5.1 Global Colorectal Cancer Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Market Size (2019-2030)
6.2 North America Colorectal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Market Size (2019-2030)
7.2 Europe Colorectal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Colorectal Cancer Introduction
11.1.4 Roche Revenue in Colorectal Cancer Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Debiopharm
11.2.1 Debiopharm Company Detail
11.2.2 Debiopharm Business Overview
11.2.3 Debiopharm Colorectal Cancer Introduction
11.2.4 Debiopharm Revenue in Colorectal Cancer Business (2019-2024)
11.2.5 Debiopharm Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Detail
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Colorectal Cancer Introduction
11.3.4 Merck Kgaa Revenue in Colorectal Cancer Business (2019-2024)
11.3.5 Merck Kgaa Recent Development
11.4 Vaccinogen
11.4.1 Vaccinogen Company Detail
11.4.2 Vaccinogen Business Overview
11.4.3 Vaccinogen Colorectal Cancer Introduction
11.4.4 Vaccinogen Revenue in Colorectal Cancer Business (2019-2024)
11.4.5 Vaccinogen Recent Development
11.5 Aeterna Zentaris
11.5.1 Aeterna Zentaris Company Detail
11.5.2 Aeterna Zentaris Business Overview
11.5.3 Aeterna Zentaris Colorectal Cancer Introduction
11.5.4 Aeterna Zentaris Revenue in Colorectal Cancer Business (2019-2024)
11.5.5 Aeterna Zentaris Recent Development
11.6 Keryx
11.6.1 Keryx Company Detail
11.6.2 Keryx Business Overview
11.6.3 Keryx Colorectal Cancer Introduction
11.6.4 Keryx Revenue in Colorectal Cancer Business (2019-2024)
11.6.5 Keryx Recent Development
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Detail
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Colorectal Cancer Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2019-2024)
11.7.5 Spectrum Pharmaceuticals Recent Development
11.8 Mologen
11.8.1 Mologen Company Detail
11.8.2 Mologen Business Overview
11.8.3 Mologen Colorectal Cancer Introduction
11.8.4 Mologen Revenue in Colorectal Cancer Business (2019-2024)
11.8.5 Mologen Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Colorectal Cancer Introduction
11.9.4 Amgen Revenue in Colorectal Cancer Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Bayer Healthcare
11.10.1 Bayer Healthcare Company Detail
11.10.2 Bayer Healthcare Business Overview
11.10.3 Bayer Healthcare Colorectal Cancer Introduction
11.10.4 Bayer Healthcare Revenue in Colorectal Cancer Business (2019-2024)
11.10.5 Bayer Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
